Stay updated on GMI-1271 Combo with Chemo in AML Clinical Trial
Sign up to get notified when there's something new on the GMI-1271 Combo with Chemo in AML Clinical Trial page.

Latest updates to the GMI-1271 Combo with Chemo in AML Clinical Trial page
- Check7 days agoChange DetectedDifference1%
- Check14 days agoChange DetectedThe page has been updated to include new drug information related to acute myeloid leukemia, specifically mentioning Cytarabine and Idarubicin, while removing detailed descriptions of a clinical trial and its criteria.SummaryDifference14%
- Check21 days agoChange DetectedThe web page has been updated from version 2.14.3 to version 2.14.4.SummaryDifference0.6%
- Check29 days agoNo Change Detected
- Check36 days agoChange DetectedDifference0.6%
- Check51 days agoChange DetectedDifference0.6%
- Check65 days agoChange DetectedThe page has removed a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products.SummaryDifference2%
Stay in the know with updates to GMI-1271 Combo with Chemo in AML Clinical Trial
Enter your email address, and we'll notify you when there's something new on the GMI-1271 Combo with Chemo in AML Clinical Trial page.